Retinal neuroprotective effects of quercetin in streptozotocin-induced diabetic rats

Experimental Eye Research

Volumn 125, Issue , 2014, Pages 193-202

  Kumar, Binit ^a,d   Gupta, Suresh Kumar ^a   Nag, Tapas Chandra ^b   Srivastava, Sushma ^a   Saxena, Rohit ^c   Jha, Kumar Abhiram ^b   Srinivasan, Bharthu Parthasarthy ^a  

^a UNIVERSITY OF DELHI   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Aquaporin 4; Bioflavonoid; GFAP; Neuroinflammation; Quercetin

Indexed keywords

AQUAPORIN 4; CASPASE 3; CATALASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; QUERCETIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROGLIA; MICROSCOPY; MODULATION; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINAL THICKNESS; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT DURATION; WESTERN BLOTTING;

APOPTOSIS; AQUAPORIN-4; BIOFLAVONOID; GFAP; NEUROINFLAMMATION; QUERCETIN;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; AQUAPORIN 4; CASPASE 3; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; GLUTATHIONE; INTERLEUKIN-1BETA; MALE; MICROGLIA; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; QUERCETIN; RATS; RATS, WISTAR; RETINA; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84903848890     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2014.06.009     Document Type: Article

References (64)

1. Anjaneyulu M., Chopra K. Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin. Exp. Pharmacol. Physiol. 2004, 31:244-248.
2. Barber A.J., Antonetti D.A., Gardner T.W. Altered expression of retinal occludin and glial fi{ligature}brillary acidic protein in experimental diabetes. Invest. Ophthalmol.Vis. Sci. 2000, 41:3561-3568.
3. Barber A.J., Lieth E., Khin S.A., Antonetti D.A., Buchanan A.G., Gardner T.W. Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. J.Clin. Invest. 1998, 102:783-791.
4. Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999, 48:1-9.
5. Bringmann A., Pannicke T., Grosche J., Francke M., Wiedemann P., Skatchkov S.N., Osborne N.N., Reichenbach A. Müller cells in the healthy and diseased retina. Prog. Retin. Eye Res. 2006, 25:397-424.
6. Bringmann A., Uckermann O., Pannicke T., Iandiev I., Reichenbach A., Wiedemann P. Neuronal versus glial cell swelling in the ischaemic retina. Acta Ophthalmol. Scand. 2005, 83:528-538.
7. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
8. Cabrera DeBuc D., Somfai G.M. Early detection of retinal thickness changes in diabetes using optical coherence tomography. Med. Sci. Monit. 2010, 16:MT15-21.
9. Cao X., Liu M., Tuo J., Shen D., Chan C.C. The effects of quercetin in cultured human RPE cells under oxidative stress and in Ccl2/Cx3cr1 double deficient mice. Exp. Eye Res. 2010, 91:15-25.
10. Carmo A., Cunha-Vaz J.G., Carvalho A.P., Lopes M.C. L-arginine transport in retinas from streptozotocin diabetic rats: correlation with the level of IL-1 beta and NO synthase activity. Vision Res. 1999, 39:3817-3823.
11. Chen Y., Li X.X., Xing N.Z., Cao X.G. Quercetin inhibits choroidal and retinal angiogenesis invitro. Graefes Arch. Clin. Exp. Ophthalmol. 2008, 246:373-378.
12. Cho S.Y., Park S.J., Kwon M.J., Jeong T.S., Bok S.H., Choi W.Y., Jeong W.I., Ryu S.Y., Do S.H., Lee C.S., Song J.C., Jeong K.S. Quercetin suppresses proinflammatory cytokines production through MAP kinases andNF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Mol. Cell. Biochem. 2003, 243:153-160.
13. Choi Y.J., Jeong Y.J., Lee Y.J., Kwon H.M., Kang Y.H. (-) Epigallocatechin gallate and quercetin enhance survival signaling in response to oxidant-induced human endothelial apoptosis. J.Nutr. 2005, 135:707-713.
14. Cornish K.M., Williamson G., Sanderson J. Quercetin metabolism in the lens: role in inhibition of hydrogen peroxide induced cataract. Free Radic. Biol. Med. 2002, 33:63-70.
15. Da T., Verkman A.S. Aquaporin-4 gene disruption in mice protects against impaired retinal function and cell death after ischemia. Invest. Ophthalmol. Vis. Sci. 2004, 45:4477-4483.
16. The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N.Engl. J. Med. 1993, 329:977-986. DCCT Research Group.
17. Demircan N., Safran B.G., Soylu M., Ozcan A.A., Sizmaz S. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye (Lond) 2006, 20:1366-1369.
18. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the diabetes control and complications trial. Arch. Ophthalmol. 2008, 126:1707-1715. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.
19. Eichler W., Kuhrt H., Hoffmann S., Wiedemann P., Reichenbach A. VEGF release by retinal glia depends on both oxygen and glucose supply. Neuroreport 2000, 11:3533-3537.
20. El-Asrar A.M.A., Dralands L., Missotten L., Al-Jadaan I.A., Geboes K. Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest. Ophthalmol. Vis. Sci. 2004, 45:2760-2766.
21. El-Asrar A.M.A., Maimone D., Morse P.H., Gregory S., Reder A.T. Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am. J. Ophthalmol. 1992, 114:731-736.
22. Gitika B., Sai Ram M., Sharma S.K., Ilavazhagan G., Banerjee P.K. Quercetin protects C6 glial cells from oxidative stress induced by tertiary-butylhydroperoxide. Free Radic. Res. 2006, 40:95-102.
23. Gupta S.K., Kumar B., Nag T.C., Agrawal S.S., Agrawal R., Agrawal P., Saxena R., Srivastava S. Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J.Ocul. Pharmacol. Ther. 2011, 27:123-130.
24. Gupta S.K., Kumar B., Srinivasan B.P., Nag T.C., Srivastava S., Saxena R., Aggarwal A. Retinoprotective effects of Moringa oleifera via antioxidant, anti-inflammatory, and anti-angiogenic mechanisms in streptozotocin-induced diabetic rats. J.Ocul. Pharmacol.Ther. 2013, 29:419-426.
25. Gupta S.K., Kumar B., Nag T.C., Srinivasan B.P., Srivastava S., Gaur S., Saxena R. Effects of Trigonella foenum-graecum (L.) on retinal oxidative stress, and proinflammatory and angiogenic molecular biomarkers in streptozotocin-induced diabetic rats. Mol. Cell. Biochem. 2014, 388:1-9.
26. Hernández C., Simó R. Neuroprotection in diabetic retinopathy. Curr. Diabetes Rep. 2012, 12:329-337.
27. Huang H., Gandhi J.K., Zhong X., Wei Y., Gong J., Duh E.J., Vinores S.A. TNF alpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis. Invest. Ophthalmol. Vis. Sci. 2011, 52:1336-1344.
28. Ishikawa Y., Kitamura M. Anti-apoptotic effect of quercetin: intervention in the JNK-and ERK-mediated apoptotic pathways. Kidney Int. 2000, 58:1078-1087.
29. Joussen A.M., Poulaki V., Mitsiades N., Kirchhof B., Koizumi K., Döhmen S., Adamis A.P. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J. 2002, 16:438-440.
30. Kao T.K., Ou Y.C., Raung S.L., Lai C.Y., Liao S.L., Chen C.J. Inhibition of nitric oxide production by quercetin in endotoxin/cytokine-stimulated microglia. Life Sci. 2010, 86:315-321.
31. Kizawa J., Machida S., Kobayashi T., Gotoh Y., Kurosaka D. Changes of oscillatory potentials and photopic negative response in patients with early diabetic retinopathy. Jpn. J. Ophthalmol. 2006, 50:367-373.
32. Kowluru R.A., Chakrabarti S., Chen S. Re-institution of good metabolic control in diabetic rats and activation of caspase-3 and nuclear transcriptional factor (NF-kappaB) in the retina. Acta Diabetol. 2004, 41:194-199.
33. Kowluru R.A., Chan P.S. Oxidative stress and diabetic retinopathy. Exp. Diabetes. Res. 2007, 2007:43603.
34. Kowluru R.A., Koppolu P. Diabetes-induced activation of Caspase-3 in retina: effect of antioxidant therapy. Free Radic. Res. 2002, 36:993-999.
35. Kowluru R.A., Odenbach S. Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. Br. J. Ophthalmol. 2004, 88:1343-1347.
36. Kowluru R.A., Zhong Q., Kanwar M. Metabolic memory and diabetic retinopathy: role of inflammatory mediators in retinal pericytes. Exp. Eye Res. 2010, 90:617-623.
37. Krady J.K., Basu A., Allen C.M., Xu Y., LaNoue K.F., Gardner T.W., Levison S.W. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 2005, 54:1559-1565.
38. Kumar B., Gupta S.K., Nag T.C., Srivastava S., Saxena R. Green tea prevents hyperglycemia-induced retinal oxidative stress and inflammation in streptozotocin-induced diabetic rats. Ophthalmic Res. 2012, 47:103-108.
39. Kumar B., Gupta S.K., Srinivasan B.P., Nag T.C., Srivastava S., Saxena R., Jha K.A. Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats. Microvasc. Res. 2013, 87:65-74.
40. Lasta M., Pemp B., Schmid D., Boltz A., Kaya S., Palkovits S., Werkmeiste r R., Howorka K., Popa-Cherecheanu A., Garhöfer G., Schmetterer L. Neurovascular dysfunction precedes neural dysfunction in the retina of patients with type 1 diabetes. Invest. Ophthalmol. Vis. Sci. 2013, 54:842-847.
41. Lee C.S., Jeong E.B., Kim Y.J., Lee M.S., Seo S.J., Park K.H., Lee M.W. Quercetin-3-O-(2″-galloyl)-α-l-rhamnopyranoside inhibits TNF-α-activated NF-κB-induced inflammatory mediator production by suppressing ERK activation. Int. Immunopharmacol. 2013, 16:481-487.
42. Lieth E., Barber A., Xu B., Dice C., Ratz M.J., Tanase D., Strother J.M. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Diabetes 1998, 47:815-820.
43. Martin P.M., Roon P., Van Ells T.K., Ganapathy V., Smith S.B. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest. Ophthalmol. Vis. Sci. 2004, 45:3330-3336.
44. Matsui K., Hosoi N., Tachibana M. Active role of glutamate uptake in the synaptic transmission from retinal nonspiking neurons. J.Neurosci. 1999, 19:6755-6766.
45. Mizutani M., Gerhardinger C., Lorenzi M. Müller cell changes in human diabetic retinopathy. Diabetes 1998, 47:445-449.
46. Mohr S., Xi X., Tang J., Kern T.S. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes 2002, 51:1172-1179.
47. Moon S.K., Cho G.O., Jung S.Y., Gal S.W., Kwon T.K., Lee Y.C., Madamanchi N.R., Kim C.H. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem. Biophys. Res. Commun. 2003, 301:1069-1078.
48. Nagelhus E.A., Horio Y., Inanobe A., Fujita A., Haug F.M., Nielsen S., Kurachi Y., Ottersen O.P. Immunogold evidence suggests that coupling of K+ siphoning and water transport in rat retinal Muller cells is mediated by a coenrichment of Kir4.1 and AQP4 in specific membrane domains. Glia 1999, 26:47-54.
49. Nagelhus E.A., Veruki M.L., Torp R., Haug F.M., Laake J.H., Nielsen S., Ottersen O.P. Aquaporin-4 water channel protein in the rat retina and optic nerve: polarized expression in Müller cells and fibrous astrocytes. J.Neurosci. 1998, 18:2506-2519.
50. Nakayama M., Aihara M., Chen Y.N., Araie M., Tomita-Yokotani K., Iwashina T. Neuroprotective effects of flavonoids on hypoxia-, glutamate-, and oxidative stress-induced retinal ganglion cell death. Mol. Vis. 2011, 17:1784-1793.
51. Newman E.A. Acid effl{ligature}ux from retinal glial cells generated by sodium bicarbonate cotransport. J.Neurosci. 1996, 16:159-168.
52. Newman E.A., Reichenbach A. The Müller cell: a functional element of the retina. Trends Neurosci. 1996, 19:307-317.
53. Pandey A.K., Patnaik R., Muresanu D.F., Sharma A., Sharma H.S. Quercetin in hypoxia-induced oxidative stress: novel target for neuroprotection. Int. Rev. Neurobiol. 2012, 102:107-146.
54. Park S.H., Park J.W., Park S.J., Kim K.Y., Chung J.W., Chun M.H., Oh S.J. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia 2003, 46:1260-1268.
55. Sharma V., Mishra M., Ghosh S., Tewari R., Basu A., Seth P., Sen E. Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection. Brain Res. Bull. 2007, 73:55-63.
56. Simó R., Hernández C. European consortium for the early treatment of diabetic retinopathy (EUROCONDOR).Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications. Br. J. Ophthalmol. 2012, 96:1285-1290.
57. Spencer J.P. The interactions of flavonoids within neuronal signalling pathways. Genes. Nutr. 2007, 2:257-273.
58. Stem M.S., Gardner T.W. Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications. Curr. Med. Chem. 2013, 20:3241-3250.
59. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group.
60. Williams M., Hogg R.E., Chakravarthy U. Antioxidants and diabetic retinopathy. Curr. Diabetes Rep. 2013, 13:481-487.
61. Williams R.J., Spencer J.P., Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Radic. Biol. Med. 2004, 36:838-849.
62. Zhang X., Wang N., Barile G.R., Bao S., Gillies M. Diabetic retinopathy: neuron protection as a therapeutic target. Int. J. Biochem. Cell. Biol. 2013, 45:1525-1529.
63. Zhong Q., Kowluru R.A. Diabetic retinopathy and damage to mitochondrial structure and transport machinery. Invest. Ophthalmol. Vis. Sci. 2011, 52:8739-8746.
64. Zhuang P., Shen Y., Lin B.Q., Zhang W.Y., Chiou G.C. Effect of Quercetin on formation of choroidal neovascularization (CNV) in age-related macular degeneration(AMD). Yan KeXueBao 2011, 26:23-29.